Last 48 quarters of trend data · Healthcare · Diagnostics & Lab Testing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 29.79 | 23.92 | 19.23 | 19.91 | 31.68 | 23.00 | 23.11 | 23.09 | 33.72 | 27.80 | 20.85 | 20.30 | — | 23.82 | 24.45 | 20.62 | 58.81 | 11.31 | 13.01 | 10.83 | 11.74 |
| — | +4.0% | -16.8% | -13.8% | -6.1% | -17.2% | +10.8% | +13.7% | — | +16.7% | -14.7% | -1.5% | — | +110.7% | +88.0% | +90.4% | +401.1% | +13.2% | +4.5% | +54.6% | +156.1% | |
| P/S Ratio | 2.06 | 1.65 | 1.54 | 1.56 | 1.48 | 1.69 | 1.56 | 1.47 | 1.45 | 1.44 | 1.33 | 1.46 | 1.59 | 1.43 | 1.52 | 1.44 | 1.23 | 1.39 | 1.60 | 1.36 | 1.60 |
| — | -2.1% | -1.7% | +6.6% | +2.4% | +17.3% | +17.5% | +0.7% | -8.8% | +0.4% | -12.4% | +0.9% | +29.8% | +2.8% | -4.7% | +5.8% | -23.5% | -3.7% | +5.4% | +5.3% | +67.2% | |
| P/B Ratio | 3.56 | 2.84 | 2.66 | 2.53 | 2.42 | 2.76 | 2.60 | 2.36 | 2.39 | 2.30 | 2.14 | 2.32 | 2.45 | 2.22 | 2.10 | 1.69 | 1.78 | 1.58 | 1.79 | 1.98 | 2.52 |
| — | +2.9% | +2.4% | +7.3% | +1.0% | +19.7% | +21.6% | +1.6% | -2.1% | +4.0% | +2.1% | +37.0% | +37.4% | +40.4% | +17.0% | -14.6% | -29.4% | -29.1% | -21.0% | -7.8% | +38.8% | |
| P/FCF | 23.36 | 15.25 | 18.29 | 78.43 | 10.64 | 21.41 | 10.17 | — | 7.26 | 29.20 | 9.91 | — | 11.70 | 25.63 | 19.40 | 160.63 | 8.40 | 14.76 | 10.87 | 22.29 | 11.86 |
| — | -28.8% | +79.8% | — | +46.6% | -26.7% | +2.6% | — | -38.0% | +13.9% | -48.9% | — | +39.2% | +73.7% | +78.4% | +620.7% | -29.1% | +63.3% | -27.1% | +338.8% | +86.3% | |
| EV / EBITDA | 15.76 | 13.53 | 11.73 | 12.66 | 12.41 | 13.50 | 12.38 | 13.07 | 16.19 | 15.08 | 12.66 | 12.81 | — | 13.07 | 13.44 | 12.42 | 24.23 | 10.74 | 11.07 | 7.33 | 7.96 |
| — | +0.2% | -5.3% | -3.2% | -23.3% | -10.5% | -2.2% | +2.1% | — | +15.3% | -5.9% | +3.1% | — | +21.8% | +21.5% | +69.3% | +204.3% | +54.9% | +50.3% | +45.3% | +107.9% | |
| EV / EBIT | 24.23 | 20.44 | 16.74 | 18.93 | 28.04 | 19.50 | 19.33 | 19.45 | 25.35 | 24.01 | 18.13 | 17.70 | 28.29 | 19.98 | 22.30 | 18.14 | 63.78 | 15.08 | 14.85 | 9.65 | 10.57 |
| — | +4.9% | -13.4% | -2.7% | +10.6% | -18.8% | +6.6% | +9.9% | -10.4% | +20.2% | -18.7% | -2.4% | -55.6% | +32.5% | +50.1% | +87.9% | +503.2% | +76.0% | +56.5% | +58.7% | +141.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 26.8% | 29.1% | 29.8% | 26.5% | 26.2% | 28.8% | 29.7% | 28.3% | 26.9% | 27.6% | 28.8% | 28.2% | 27.1% | 27.8% | 27.8% | 28.0% | 26.4% | 30.9% | 32.2% | 31.6% | 33.9% |
| — | +1.1% | +0.5% | -6.4% | -2.7% | +4.4% | +3.1% | +0.3% | -0.6% | -1.0% | +3.6% | +0.9% | +2.6% | -9.9% | -13.9% | -11.5% | -22.1% | -9.4% | -2.1% | -17.7% | -20.1% | |
| Operating Margin | 10.9% | 10.6% | 12.1% | 10.9% | 10.9% | 11.1% | 11.2% | 9.7% | 6.5% | 7.7% | 9.2% | 10.1% | -4.0% | 8.3% | 8.8% | 10.9% | 2.5% | 13.0% | 14.7% | 17.6% | 18.0% |
| — | -5.2% | +8.2% | +12.3% | +67.1% | +43.8% | +22.2% | -3.6% | +260.6% | -6.2% | +4.3% | -6.8% | -264.0% | -36.7% | -40.2% | -38.5% | -86.3% | -30.9% | -20.0% | -30.6% | -37.5% | |
| Net Margin | 6.3% | 6.9% | 8.0% | 7.9% | 4.7% | 7.3% | 6.7% | 6.4% | 4.3% | 5.2% | 6.4% | 7.2% | -5.5% | 6.0% | 6.2% | 7.0% | 2.1% | 12.3% | 12.3% | 12.6% | 13.6% |
| — | -5.9% | +18.7% | +23.4% | +8.8% | +42.0% | +5.8% | -11.4% | +178.2% | -14.0% | +2.4% | +2.4% | -366.0% | -51.3% | -49.2% | -44.4% | -84.8% | -14.9% | +0.8% | -31.8% | -34.8% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.5% | 3.0% | 3.4% | 3.2% | 1.9% | 3.0% | 2.8% | 2.6% | 1.8% | 2.1% | 2.6% | 2.9% | -2.1% | 2.2% | 2.0% | 2.1% | 0.8% | 3.4% | 3.4% | 4.7% | 5.3% |
| — | -1.0% | +21.5% | +23.1% | +7.6% | +45.3% | +10.3% | -9.6% | +183.3% | -4.8% | +30.2% | +38.2% | -381.4% | -36.1% | -41.8% | -55.5% | -85.8% | -39.1% | -26.4% | -40.8% | -49.9% | |
| ROA | 4.8% | 1.4% | 1.6% | 1.5% | 0.9% | 1.4% | 1.3% | 1.2% | 0.8% | 1.0% | 1.2% | 1.4% | -1.0% | 1.1% | 1.0% | 1.1% | 0.4% | 1.8% | 1.7% | 2.4% | 2.7% |
| — | -2.4% | +19.0% | +25.3% | +15.9% | +50.0% | +8.0% | -13.7% | +178.0% | -9.6% | +23.9% | +30.0% | -361.2% | -39.6% | -42.8% | -55.9% | -85.8% | -38.4% | -23.8% | -37.1% | -44.6% | |
| ROIC | 7.8% | 2.0% | 2.2% | 1.9% | 1.9% | 2.0% | 2.1% | 1.7% | 1.2% | 1.4% | 1.6% | 1.8% | -0.7% | 1.4% | 1.4% | 1.5% | 0.4% | 1.8% | 2.0% | 3.3% | 3.7% |
| — | -1.6% | +9.2% | +10.8% | +62.4% | +47.7% | +27.9% | -2.6% | +267.5% | -4.8% | +17.8% | +15.9% | -261.7% | -19.7% | -33.4% | -54.0% | -88.4% | -54.5% | -43.5% | -38.2% | -45.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.83 | 0.76 | 0.78 | 0.83 | 0.83 | 0.83 | 0.77 | 0.78 | 0.90 | 0.94 | 0.74 | 0.75 | 0.75 | 0.80 | 0.71 | 0.61 | 0.62 | 0.62 | 0.61 | 0.59 | 0.62 |
| — | -7.8% | +1.8% | +5.7% | -7.4% | -12.1% | +3.5% | +4.7% | +19.5% | +17.6% | +5.6% | +23.3% | +22.2% | +29.3% | +16.4% | +3.7% | +0.2% | +3.2% | -2.1% | -7.5% | -13.8% | |
| Debt / EBITDA | 3.28 | 11.58 | 10.73 | 12.92 | 12.99 | 12.72 | 11.59 | 13.23 | 18.79 | 18.57 | 13.23 | 12.54 | — | 14.33 | 14.69 | 13.33 | 25.30 | 12.34 | 11.70 | 7.00 | 6.55 |
| — | -9.0% | -7.4% | -2.4% | -30.9% | -31.5% | -12.4% | +5.5% | — | +29.6% | -10.0% | -5.9% | — | +16.1% | +25.6% | +90.3% | +286.2% | +95.2% | +72.8% | +42.1% | +43.2% | |
| Current Ratio | 1.42 | 1.41 | 1.80 | 1.73 | 1.42 | 1.55 | 1.50 | 1.84 | 1.44 | 1.44 | 0.88 | 0.88 | 1.17 | 1.36 | 2.35 | 1.63 | 1.50 | 1.73 | 1.90 | 1.98 | 1.92 |
| — | -9.3% | +19.4% | -6.0% | -1.3% | +7.8% | +71.2% | +109.3% | +23.6% | +5.6% | -62.5% | -46.1% | -22.3% | -21.4% | +23.2% | -17.8% | -21.6% | -16.8% | -10.8% | +18.3% | +15.0% | |
| Quick Ratio | 1.23 | 1.22 | 1.53 | 1.54 | 1.23 | 1.35 | 1.32 | 1.60 | 1.30 | 1.30 | 0.77 | 0.76 | 1.02 | 1.20 | 2.12 | 1.46 | 1.35 | 1.55 | 1.74 | 1.81 | 1.77 |
| — | -10.1% | +16.2% | -3.8% | -4.7% | +4.3% | +71.1% | +111.4% | +26.9% | +7.7% | -63.7% | -48.2% | -24.4% | -22.2% | +22.1% | -19.5% | -23.8% | -20.3% | -12.1% | +17.2% | +16.0% | |
| Interest Coverage | 5.94 | 6.55 | 7.23 | 6.80 | 4.47 | 7.02 | 6.34 | 5.91 | 3.90 | 5.18 | 6.62 | 7.34 | 4.48 | 5.75 | 5.12 | 6.37 | 1.90 | 7.81 | 9.47 | 16.17 | 16.92 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LH stock.
Labcorp Holdings Inc.'s current P/E is 29.8x. The average P/E over the last 4 quarters is 23.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Labcorp Holdings Inc.'s current operating margin is 10.9%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Labcorp Holdings Inc.'s business trajectory between earnings reports.